{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:38:05Z","timestamp":1794814685737,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C17422\/A25154"],"award-info":[{"award-number":["C17422\/A25154"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C38317\/A24043"],"award-info":[{"award-number":["C38317\/A24043"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C38317\/A24043"],"award-info":[{"award-number":["C38317\/A24043"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C38317\/A24043"],"award-info":[{"award-number":["C38317\/A24043"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C38317\/A24043"],"award-info":[{"award-number":["C38317\/A24043"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,12,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The diagnosis, management and prognosis of microinvasive breast carcinoma remain controversial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed the outcomes of patients with DCIS with and without microinvasion diagnosed between 2003 and 2012 within the Sloane project.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Microinvasion was recorded in 521 of 11,285 patients (4.6%), with considerable variation in reported incidence among screening units (0\u201325%). Microinvasion was associated with high-grade DCIS, larger DCIS size, comedo necrosis and solid, cribriform\u00a0architecture (all <jats:italic>P<\/jats:italic>\u2009<jats:italic>&lt;<\/jats:italic>\u20090.001). Microinvasion was more frequent in patients who underwent mastectomy compared with breast-conserving surgery (BCS) (6.9% vs 3.6%, <jats:italic>P<\/jats:italic>\u2009<jats:italic>&lt;<\/jats:italic>\u2009\u20090.001), and in those undergoing axillary nodal surgery (60.4% vs 30.3%, <jats:italic>P<\/jats:italic>\u2009<jats:italic>&lt;<\/jats:italic>\u2009\u20090.001) including the subset undergoing BCS (43.4% vs 8.5%, <jats:italic>P<\/jats:italic>\u2009<jats:italic>&lt;<\/jats:italic>\u20090.001). Nodal metastasis rate was low and not statistically significant difference from the\u00a0DCIS only group\u00a0(<jats:italic>P<\/jats:italic>\u2009=\u20090.68). Following median follow-up of 110 months, 3% of patients had recurrent ipsilateral high-grade DCIS, and 4.2% developed invasive carcinoma. The subsequent ipsilateral invasion was of Grade 3 in 71.4% of patients with microinvasion vs 30.4% in DCIS without microinvasion (<jats:italic>P<\/jats:italic>\u2009=\u20090.02). Distant metastasis and breast cancer mortality were higher with microinvasion compared with DCIS only (1.2% vs 0.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.01 and 2.1% vs 0.8%; <jats:italic>P<\/jats:italic>\u2009=\u20090.005).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The higher breast cancer mortality with microinvasion indicates a more aggressive disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-022-01983-4","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T19:02:49Z","timestamp":1665601369000},"page":"2125-2132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion \u22641\u2009mm in size)\u2014results from the UK Sloane Project"],"prefix":"10.1038","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-8705","authenticated-orcid":false,"given":"Abeer M.","family":"Shaaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-4409","authenticated-orcid":false,"given":"Karen","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-4904","authenticated-orcid":false,"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-4111","authenticated-orcid":false,"given":"Elinor","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8344-4958","authenticated-orcid":false,"given":"Anthony","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Stobart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthurun","family":"Mylvaganam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Litherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Brace-McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Dulson-Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olive","family":"Kearins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5292-8474","authenticated-orcid":false,"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-8910","authenticated-orcid":false,"given":"Sarah E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"1983_CR1","unstructured":"The WHO Classification of Tumours Editorial Board. WHO Classification of tumours\u2014breast tumours, 5th Edition. Lyon: International Agency for Research On Cancer (IARC); 2019."},{"key":"1983_CR2","unstructured":"Guidelines Working Group of the UK National Coordinating Committee for Breast Pathology. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. https:\/\/www.rcpath.org\/profession\/guidelines\/cancer-datasets-and-tissue-pathways.html. Accessed 1 September 2022. The Royal College of Pathologists; 2016."},{"key":"1983_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/s0002-9610(03)00166-1","volume":"186","author":"TL Adamovich","year":"2003","unstructured":"Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg. 2003;186:112\u20136. https:\/\/doi.org\/10.1016\/s0002-9610(03)00166-1.","journal-title":"Am J Surg"},{"key":"1983_CR4","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1245\/s10434-019-07556-9","volume":"26","author":"CD Champion","year":"2019","unstructured":"Champion CD, Ren Y, Thomas SM, Fayanju OM, Rosenberger LH, Greenup RA, et al. DCIS with microinvasion: is it in situ or invasive disease? Ann surgical Oncol. 2019;26:3124\u201332. https:\/\/doi.org\/10.1245\/s10434-019-07556-9.","journal-title":"Ann surgical Oncol"},{"key":"1983_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ejso.2007.08.003","volume":"34","author":"RF van la Parra","year":"2008","unstructured":"van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surgical Oncol: J Eur Soc Surgical Oncol Br Assoc Surgical Oncol. 2008;34:631\u20135. https:\/\/doi.org\/10.1016\/j.ejso.2007.08.003.","journal-title":"Eur J Surgical Oncol: J Eur Soc Surgical Oncol Br Assoc Surgical Oncol"},{"key":"1983_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","volume":"124","author":"AM Shaaban","year":"2021","unstructured":"Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S, Wallis MG, et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br J Cancer. 2021;124:1009\u201317. https:\/\/doi.org\/10.1038\/s41416-020-01152-5.","journal-title":"Br J Cancer"},{"key":"1983_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41416-021-01281-5","volume":"124","author":"AM Shaaban","year":"2021","unstructured":"Shaaban AM, Hilton B, Clements K, Pinder SE, Thompson AM. Reply to \u201ccomment on: pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project\u201d. Br J Cancer. 2021;124:1463\u20134. https:\/\/doi.org\/10.1038\/s41416-021-01281-5.","journal-title":"Br J Cancer"},{"key":"1983_CR8","unstructured":"The National Archives. https:\/\/webarchive.nationalarchives.gov.uk\/20180903111938\/http:\/\/www.sloaneproject.co.uk\/Pathology.htm"},{"key":"1983_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","volume":"101","author":"AM Thompson","year":"2018","unstructured":"Thompson AM, Clements K, Cheung S, Pinder SE, Lawrence G, Sawyer E, et al. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project. Eur J Cancer. 2018;101:210\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2018.06.027.","journal-title":"Eur J Cancer"},{"key":"1983_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10549-017-4572-2","volume":"167","author":"V Sopik","year":"2018","unstructured":"Sopik V, Sun P, Narod SA. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ. Breast Cancer Res Treat. 2018;167:787\u201395. https:\/\/doi.org\/10.1007\/s10549-017-4572-2.","journal-title":"Breast Cancer Res Treat"},{"key":"1983_CR11","doi-asserted-by":"publisher","first-page":"101557","DOI":"10.1016\/j.suronc.2021.101557","volume":"37","author":"B Choi","year":"2021","unstructured":"Choi B, Jegatheeswaran L, Nakhoul M, Haria P, Srivastava R, Karki S, et al. Axillary staging in ductal carcinoma in situ with microinvasion: a meta-analysis. Surg Oncol. 2021;37:101557. https:\/\/doi.org\/10.1016\/j.suronc.2021.101557.","journal-title":"Surg Oncol"},{"key":"1983_CR12","doi-asserted-by":"publisher","first-page":"64182","DOI":"10.18632\/oncotarget.11639","volume":"7","author":"Y Fang","year":"2016","unstructured":"Fang Y, Wu J, Wang W, Fei X, Zong Y, Chen X, et al. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion. Oncotarget. 2016;7:64182\u201390. https:\/\/doi.org\/10.18632\/oncotarget.11639.","journal-title":"Oncotarget"},{"key":"1983_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00428-020-02959-6","volume":"478","author":"XY Chen","year":"2021","unstructured":"Chen XY, Thike AA, Koh VCY, Nasir NDM, Bay BH, Tan PH. Breast ductal carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence. Virchows Arch: Int J Pathol. 2021;478:679\u201386. https:\/\/doi.org\/10.1007\/s00428-020-02959-6.","journal-title":"Virchows Arch: Int J Pathol"},{"key":"1983_CR14","doi-asserted-by":"publisher","first-page":"e23593","DOI":"10.1097\/MD.0000000000023593","volume":"99","author":"G Zhang","year":"2020","unstructured":"Zhang G, Li C, Tian G, Cheng X, Li Y, Ma L. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis. Medicine. 2020;99:e23593. https:\/\/doi.org\/10.1097\/MD.0000000000023593.","journal-title":"Medicine"},{"key":"1983_CR15","doi-asserted-by":"publisher","first-page":"607502","DOI":"10.3389\/fonc.2020.607502","volume":"10","author":"J Si","year":"2020","unstructured":"Si J, Guo R, Pan H, Lu X, Guo Z, Han C, et al. Multiple microinvasion foci in ductal carcinoma in situ is associated with an increased risk of recurrence and worse survival outcome. Front Oncol. 2020;10:607502. https:\/\/doi.org\/10.3389\/fonc.2020.607502.","journal-title":"Front Oncol"},{"key":"1983_CR16","unstructured":"Fox S, Chen CJ, Chua B, Collins LC, Foschini MP, Mann B, et al. Ductal carcinoma in situ, variants of lobular carcinoma in situ and low grade lesions histopathology reporting guide. International Collaboration on Cancer Reporting: Sydney, Australia; 2021."},{"key":"1983_CR17","doi-asserted-by":"publisher","unstructured":"Fox SB, Webster F, Chen CJ, Chua B, Collins L, Foschini MP, et al. Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2022; e-pub ahead of print 24 July 2022; https:\/\/doi.org\/10.1111\/his.14725.","DOI":"10.1111\/his.14725"},{"key":"1983_CR18","first-page":"223","volume":"25","author":"A Maffuz","year":"2006","unstructured":"Maffuz A, Barroso-Bravo S, Najera I, Zarco G, Alvarado-Cabrero I, Rodriguez-Cuevas SA. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. J Exp Clin Cancer Res. 2006;25:223\u20137.","journal-title":"J Exp Clin Cancer Res"},{"key":"1983_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3892\/mco.2019.1891","volume":"11","author":"H Wang","year":"2019","unstructured":"Wang H, Lin J, Lai J, Tan C, Yang Y, Gu R, et al. Imaging features that distinguish pure ductal carcinoma in situ (DCIS) from DCIS with microinvasion. Mol Clin Oncol. 2019;11:313\u20139. https:\/\/doi.org\/10.3892\/mco.2019.1891.","journal-title":"Mol Clin Oncol"},{"key":"1983_CR20","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1245\/s10434-019-07475-9","volume":"26","author":"MR Flanagan","year":"2019","unstructured":"Flanagan MR, Stempel M, Brogi E, Morrow M, Cody HS 3rd. Is sentinel lymph node biopsy required for a core biopsy diagnosis of ductal carcinoma in situ with microinvasion? Ann surgical Oncol. 2019;26:2738\u201346. https:\/\/doi.org\/10.1245\/s10434-019-07475-9.","journal-title":"Ann surgical Oncol"},{"key":"1983_CR21","first-page":"1066","volume":"13","author":"BT Liu","year":"2020","unstructured":"Liu BT, Ding JN, Wang JL, Li ZS, Ding YL, Ma R. Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma. Int J Clin Exp Pathol. 2020;13:1066\u201372.","journal-title":"Int J Clin Exp Pathol"},{"key":"1983_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1097-0142(19821001)50","volume":"50","author":"MD Lagios","year":"1982","unstructured":"Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982;50:1309\u201314. https:\/\/doi.org\/10.1002\/1097-0142(19821001)50.","journal-title":"Cancer"},{"key":"1983_CR23","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2382::AID-CNCR12>3.0.CO;2-L","volume":"82","author":"SA Silver","year":"1998","unstructured":"Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion. Cancer. 1998;82:2382\u201390.","journal-title":"Cancer"},{"key":"1983_CR24","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/cncr.10451","volume":"94","author":"I de Mascarel","year":"2002","unstructured":"de Mascarel I, MacGrogan G, Mathoulin-Pelissier S, Soubeyran I, Picot V, Coindre JM. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer. 2002;94:2134\u201342. https:\/\/doi.org\/10.1002\/cncr.10451.","journal-title":"Cancer"},{"key":"1983_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","volume":"54","author":"EH Lips","year":"2022","unstructured":"Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, et al. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nat Genet. 2022;54:850\u201360. https:\/\/doi.org\/10.1038\/s41588-022-01082-3.","journal-title":"Nat Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01983-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01983-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01983-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T08:05:00Z","timestamp":1674806700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01983-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,7]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01983-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"26 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics Committee approval was not required for this study, originally conducted under the NHS Cancer Screening Programme\u2019s application to the Patient Information Advisory Group (PIAG). More recently, the study has been permitted to process personally identifiable data without consent under Regulation 5 of Statutory Instrument 2002 No. 1438: The Health Service (Control of Patient Information) Regulations 2002 (15\/CAG\/0207) in line with the following clause: \u201cquality assuring screening services to ensure they are effective and safe, and that any incidents are investigated and managed appropriately\u201d. This statutory exemption to common law permits Public Health England to process personally identifiable data for activities it is \u2018responsible and accountable to the Secretary of State for Health for\u2019, as part of its core remit for population screening.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}